Fatal Hepatic Veno-Occlusive Disease in a Phase I Study of Mylotarg and Troxatyl in Patients with Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

Publisher： Karger

E-ISSN： 1421-9662|108|3|164-167

ISSN： 0001-5792

Source： Acta Haematologica, Vol.108, Iss.3, 2002-09, pp. : 164-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase I/II trial of the combination of midostaurin (PKC412) and 5‐azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : 276-281

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gemtuzumab Ozogamicin (Mylotarg®) in Children with Refractory or Relapsed Acute Myeloid Leukemia

By  

Oncology Research and Treatment, Vol. 27, Iss. 3, 2004-07 ,pp. : 269-272

Karger

Access to resources Recommend Favorite

Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population‐based study among older breast cancer patients

By  

CANCER, Vol. 124, Iss. 5, 2018-03 ,pp. : 899-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatic Veno-Occlusive Disease following Hematopoietic Stem Cell Transplantation

By  

Acta Haematologica, Vol. 106, Iss. 1-2, 2001-09 ,pp. : 57-68

Karger

Access to resources Recommend Favorite

Angiogenesis in Acute Myeloid Leukemia and Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 170-176

Karger

Access to resources Recommend Favorite